Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open Phase I Clinical Study to Evaluate the Pharmacokinetics, Safety and Tolerability of Single Dose and Repeat Dose Topical Administrations of Clascoterone Cream, 1% in Healthy Chinese Adult Subjects

NCT06454708 is registered in ClinicalTrials.gov with Zhejiang Sunshine Mandi Pharmaceutical Co.,Ltd. as lead sponsor.

NCT NCT06454708
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06454708 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open Phase I Clinical Study to Evaluate the Pharmacokinetics, Safety and Tolerability of Single Dose and Repeat Dose Topical Administrations of Clascoterone Cream, 1% in Healthy Chinese Adult Subjects
Lead sponsor
Zhejiang Sunshine Mandi Pharmaceutical Co.,Ltd.
Phase
Phase 1
Overall status
Completed
Start date
August 1, 2024
Completion date
August 12, 2024
Enrollment
12 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acne vulgaris